Orally active indole N-oxide PDE4 inhibitors

Christopher Hulme, Rose Mathew, Kevin Moriarty, Bruce Miller, Mercy Ramanjulu, Paul Cox, John Souness, Ken M. Page, Joanne Uhl, Jeffrey Travis, Richard Labaudiniere, Fu Chih Huang, Stevan W. Djuric

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

This communication describes the synthesis and in vitro and in vivo evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. Several of the compounds presented possess low nanomolar IC50's for PDE4 inhibition and excellent in vivo activity for inhibition of TNF-α levels in LPS challenged mice (mouse endotoxemia model). Emesis studies (dog) and efficacy in a SCW arthritis model for the most potent PDE4 inhibitors are presented.

Original languageEnglish (US)
Pages (from-to)3053-3058
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume8
Issue number21
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Phosphodiesterase 4 Inhibitors
Oxides
Type 4 Cyclic Nucleotide Phosphodiesterase
Endotoxemia
Inhibitory Concentration 50
Arthritis
Vomiting
Dogs
Communication
indole
In Vitro Techniques

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Hulme, C., Mathew, R., Moriarty, K., Miller, B., Ramanjulu, M., Cox, P., ... Djuric, S. W. (1998). Orally active indole N-oxide PDE4 inhibitors. Bioorganic and Medicinal Chemistry Letters, 8(21), 3053-3058. https://doi.org/10.1016/S0960-894X(98)00572-1

Orally active indole N-oxide PDE4 inhibitors. / Hulme, Christopher; Mathew, Rose; Moriarty, Kevin; Miller, Bruce; Ramanjulu, Mercy; Cox, Paul; Souness, John; Page, Ken M.; Uhl, Joanne; Travis, Jeffrey; Labaudiniere, Richard; Huang, Fu Chih; Djuric, Stevan W.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 8, No. 21, 1998, p. 3053-3058.

Research output: Contribution to journalArticle

Hulme, C, Mathew, R, Moriarty, K, Miller, B, Ramanjulu, M, Cox, P, Souness, J, Page, KM, Uhl, J, Travis, J, Labaudiniere, R, Huang, FC & Djuric, SW 1998, 'Orally active indole N-oxide PDE4 inhibitors', Bioorganic and Medicinal Chemistry Letters, vol. 8, no. 21, pp. 3053-3058. https://doi.org/10.1016/S0960-894X(98)00572-1
Hulme, Christopher ; Mathew, Rose ; Moriarty, Kevin ; Miller, Bruce ; Ramanjulu, Mercy ; Cox, Paul ; Souness, John ; Page, Ken M. ; Uhl, Joanne ; Travis, Jeffrey ; Labaudiniere, Richard ; Huang, Fu Chih ; Djuric, Stevan W. / Orally active indole N-oxide PDE4 inhibitors. In: Bioorganic and Medicinal Chemistry Letters. 1998 ; Vol. 8, No. 21. pp. 3053-3058.
@article{7b58e3e32ea54b398b37995e19039b95,
title = "Orally active indole N-oxide PDE4 inhibitors",
abstract = "This communication describes the synthesis and in vitro and in vivo evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. Several of the compounds presented possess low nanomolar IC50's for PDE4 inhibition and excellent in vivo activity for inhibition of TNF-α levels in LPS challenged mice (mouse endotoxemia model). Emesis studies (dog) and efficacy in a SCW arthritis model for the most potent PDE4 inhibitors are presented.",
author = "Christopher Hulme and Rose Mathew and Kevin Moriarty and Bruce Miller and Mercy Ramanjulu and Paul Cox and John Souness and Page, {Ken M.} and Joanne Uhl and Jeffrey Travis and Richard Labaudiniere and Huang, {Fu Chih} and Djuric, {Stevan W.}",
year = "1998",
doi = "10.1016/S0960-894X(98)00572-1",
language = "English (US)",
volume = "8",
pages = "3053--3058",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "21",

}

TY - JOUR

T1 - Orally active indole N-oxide PDE4 inhibitors

AU - Hulme, Christopher

AU - Mathew, Rose

AU - Moriarty, Kevin

AU - Miller, Bruce

AU - Ramanjulu, Mercy

AU - Cox, Paul

AU - Souness, John

AU - Page, Ken M.

AU - Uhl, Joanne

AU - Travis, Jeffrey

AU - Labaudiniere, Richard

AU - Huang, Fu Chih

AU - Djuric, Stevan W.

PY - 1998

Y1 - 1998

N2 - This communication describes the synthesis and in vitro and in vivo evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. Several of the compounds presented possess low nanomolar IC50's for PDE4 inhibition and excellent in vivo activity for inhibition of TNF-α levels in LPS challenged mice (mouse endotoxemia model). Emesis studies (dog) and efficacy in a SCW arthritis model for the most potent PDE4 inhibitors are presented.

AB - This communication describes the synthesis and in vitro and in vivo evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. Several of the compounds presented possess low nanomolar IC50's for PDE4 inhibition and excellent in vivo activity for inhibition of TNF-α levels in LPS challenged mice (mouse endotoxemia model). Emesis studies (dog) and efficacy in a SCW arthritis model for the most potent PDE4 inhibitors are presented.

UR - http://www.scopus.com/inward/record.url?scp=17144459980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144459980&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(98)00572-1

DO - 10.1016/S0960-894X(98)00572-1

M3 - Article

C2 - 9873675

AN - SCOPUS:17144459980

VL - 8

SP - 3053

EP - 3058

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 21

ER -